| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | — | −1.7× | — |
| Price / Book | — | 2.0× | — |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | — | −1.6× | — |
| EV / EBITDA | — | −1.2× | — |
| Earnings yield | — | −14.3% | — |
| Free cash flow yield | — | −9.9% | — |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,295.22 | +4.42% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.60 | +1.90% | $623.2B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.00 | +1.88% | $508.93B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $414.83 | +1.95% | $372.35B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.85 | +2.94% | $364.77B | 19.4× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.36 | +1.44% | $280.87B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.62 | +2.24% | $259.96B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.77 | +0.79% | $253.19B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $433.99 | +2.13% | $234.63B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.62 | +1.67% | $192.96B | 22.3× | 37.5% | +29.9% |
